retail_basics Posted - 43 minutes ago

$ARDX #ardelyx let's go and make a deal!!

RonIsWrong Posted - 1 hour ago

$ARDX ownership

opportoni Posted - 5 hours ago

$ARDX Nothing new, but a concise description of where we stand here. https://www.tipranks.com/news/ardelyx-nasdaqardx-a-commercial-stage-biopharma-stock-with-growth-potential

Food4Thought Posted - 7 hours ago

$ARDX Just came across article from April 15, 2024 that Astra Zeneca published. On Impact CKD model projects up to 16.5% of population across 8 countries to suffer from Chronic Kidney Disease by 2032. Also a rise of up to 59.3% in advance-stage. AstraZeneca is heavily researching this area shows that they want get ahead of the curve and possibly see a need for early market research/penetration. I know of 1 company that can assist AZ, and that AstraZeneca had annual free cash flow of $9.116 Billion in 2023. I don't like to play cupid, but this seems like a perfect match. https://www.astrazeneca.com/media-centre/press-releases/2024/new-modelling-reveals-the-escalating-toll-of-chronic-kidney-disease-on-patients-planet-and-economies.html#:~:text=A%20new%20modelling%20analysis%20by,59.3%25%20in%20advanced%2Dstage.

Food4Thought Posted - 8 hours ago

$ARDX Below is what you call diversified Leadership. To me, this team can take to our goals for long-term holders here.

Food4Thought Posted - 8 hours ago

$ARDX Overall institutions still bought at 2:1 versus selling for 2024 Q1 ending March 31st, 2024.

Food4Thought Posted - 8 hours ago

$ARDX Of the Top 11 Institutions, 8 increased position , 1 new comer and 2 decreased positions (profit taking a small amount considering they were at 3x and 2x). Around 2:1 additions versus subtractions. Big Boys actions speaking louder than words. Remain extremely

FerreroRocher Posted - 14 hours ago

$ARDX https://events.blackthorn.io/en/5f4bLi97/a-new-paradigm-rethinking-hyperphosphatemia-management-3a3VUzcq5/overview

FerreroRocher Posted - 14 hours ago

$ARDX XPHOZAH® is well advertised. https://twitter.com/Neph_Times/status/1790787971529978173?s=19

badgermobile Posted - 23 hours ago

$ARDX I agree the shorts have realized the battle is over run for cover. It is now Custer’s last stand and who wants that loss.

bams1017 Posted - 1 day ago

$ARDX Days to cover Short Interest. Don't know how widely this data point (number) is followed, but if volume keeps this low for the next few weeks (and of course, shorts don't cover accordingly) - we should see a huge spike in this number. And my thought is that a larger number would likely attract a lot of interest.

Jeffkad Posted - 1 day ago

$ARDX fellow ardelyxians: here’s a question for a lazy Saturday morning: given the early very positive Q2 script #s (Frank/twitter), will shorts hold their ground into Q2 (early Aug) or will they start to cover beforehand?

Haha1978 Posted - 1 day ago

$ARDX It just proves 1 day in the hospital covers the X drug. They really need to do a cost benefit analysis to try and show being on the drug reduces hospital overnight stays by more than a day t9 justify the cost to insurance.

marvessa Posted - 1 day ago

$ARDX 15 EOY

holdi Posted - 1 day ago

$ARDX Cost $28000 per day 8 days of hospitalization of CKD patients with CVD https://cme.kidney.org/spa/courses/resource/2024-spring-clinical-meetings/event/home/posters/abstracts?abstractId=4660

FerreroRocher Posted - 1 day ago

$ARDX https://twitter.com/HCPLiveNews/status/1791130737749491922

FerreroRocher Posted - 1 day ago

$ARDX https://cme.kidney.org/spa/courses/resource/2024-spring-clinical-meetings/event/home/posters/abstracts?abstractId=4878

FerreroRocher Posted - 1 day ago

$ARDX https://cme.kidney.org/spa/courses/resource/2024-spring-clinical-meetings/event/home/posters/abstracts?abstractId=4735

FerreroRocher Posted - 1 day ago

$ARDX https://cme.kidney.org/spa/courses/resource/2024-spring-clinical-meetings/event/home/posters/abstracts?abstractId=4780

steven1x Posted - 1 day ago

$ARDX if missed https://www.globenewswire.com/en/news-release/2024/05/16/2883372/0/en/Ardelyx-Presents-Additional-Data-at-the-NKF-2024-Spring-Clinical-Meetings-on-XPHOZAH-tenapanor.html

EV_Investor Posted - 1 day ago

$ARDX good weekend to all. Well everyone except the person responsible for us no longer getting weekly scripts. Whoever it is may you have extreme flatulence at the most inopportune time.

prodigy81 Posted - 1 day ago

@h8ster Great. Do you keep buying options every month? I would like to make home run for this. I can still recall I sold my $NVAX and $ARDX too early (With loss for the $NVAX and only a few thousand dollars earned for the $ARDX). I will hold this one for a bit longer so that make sure I have a good return this time. By the ways, why bearish on this?

Colinmos Posted - 1 day ago

$ARDX small wins, y’all have a good weekend

ardxholder Posted - 1 day ago

$ARDX https://www.marketbeat.com/instant-alerts/nasdaq-ardx-sec-filing-2024-05-17/

Hawksssss Posted - 1 day ago

$ARDX green is green is green

FerreroRocher Posted - 1 day ago

$ARDX

FerreroRocher Posted - 1 day ago

$ARDX "Our successes have enabled our team to experience the full range of drug development—from the development of our in-house scientific platform, which has enabled pioneering insights into new biological mechanisms, to the discovery and development of first-in-class therapies that exploit those mechanisms, through to regulatory approval. We are seeking a Clinical trial professional with excellent attention to detail and communication/organizational skills to assist with the management of trial related records based on applicable US (and international, if applicable) regulations and guidelines as well as company Work Instructions, and procedures."

FerreroRocher Posted - 1 day ago

$ARDX New job posting for "Clinical Records Specialist". https://www.linkedin.com/jobs/view/3929256077 Job Description: Lots of biotech companies say they are unique. At Ardelyx, Inc, we believe we truly are. With an ethos of constant learning, belief in each other, and trusted to spread our wings beyond what’s expected, we have not forgotten why we’re here—to work closely with patients, the medical community, and each other, to deliver innovative medicines that matter. Our successes have enabled our team to experience the full range of drug development—from the development of our in-house scientific platform, which has enabled pioneering insights into new biological mechanisms, to the discovery and development of first-in-class therapies that exploit those mechanisms, through to regulatory approval.

FerreroRocher Posted - 1 day ago

$ARDX https://www.kidney.org/content/corporate-membership-program

meadowlarkzac Posted - 1 day ago

$ARDX the 7.8 is because BO at 31.00. My oracle told me this when we discussed when the sun and moon align for favorable conditions.